TSX closed
Loading markets…

Advertisement

Stocks

What's Going On With Manhattan Uranium Discovery Corp. Stock Tuesday?

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:MANU.V

Get MANU alerts:

Photos provided by Pexels

Manhattan Uranium Discovery Corp. saw a notable uptick in its stock price this week, despite a challenging year-to-date performance.

Manhattan Uranium Discovery Corp. (MANU.V) experienced a 6.67% increase in its stock price on Tuesday, closing at C$0.23. However, the stock has struggled over the past week, down 2.04%, and has seen a significant decline of 48.94% year-to-date. This fluctuation comes amidst recent strategic acquisitions and a focus on enhancing its presence in the uranium market.

Advertisement

Manhattan Uranium Discovery Corp.

MANU.V

Full stock page →

MANU.V

Manhattan Uranium Discovery Corp.

Source:WealthAwesomeWealthAwesome
$0.23 (-48.94%)
84 day period
$0.20$0.34$0.47May 8Jul 14Sep 14

Market cap

$24.77M

52W high

$0.60

52W low

$0.19

1W change

-2.04%

Beta

1.59

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on MANU's historical volatility

HistoricalForecast68%95%
C$0.05C$0.21C$0.37C$0.53C$0.68C$0.84TodayMay 8Jul 14Sep 14Oct 27Dec 10Jan 22

30-Day Vol

117.6%

Annualized

90-Day Vol

106.0%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$0.20

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.23C$0.15C$0.34
60 trading daysC$0.21C$0.12C$0.38
90 trading daysC$0.20C$0.10C$0.41

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Investors should carefully consider the recent performance and strategic developments of Manhattan Uranium Discovery Corp., especially in light of its substantial year-to-date decline. The company’s recent acquisitions and growing presence in the U.S. market may present opportunities, but the stock's volatility and technical indicators suggest caution.

Manhattan Uranium's Stock Shows Mixed Performance Amid Strategic Moves

The stock has traded between C$0.19 and C$0.60 over the past year, reflecting a current price at approximately 11% of its 52-week range, highlighting its volatility and potential for recovery or further decline.

Bull case

The recent acquisitions of Urano Energy and Pegasus Resources position Manhattan Uranium as a significant player in the North American uranium sector. This could lead to increased visibility and interest from investors.

Bear case

Despite these strategic moves, the stock's significant year-to-date decline and its current trading levels below key moving averages may indicate ongoing challenges for the company in attracting investor confidence.

Recent Price Action

Manhattan Uranium Discovery Corp.'s stock price saw an increase of 6.67% on Tuesday, closing at C$0.23. However, the stock has experienced a decline of 2.04% over the past week and a significant drop of 48.94% year-to-date, indicating a challenging market environment.

Company News and Developments

Advertisement

Recent headlines surrounding Manhattan Uranium include the completion of transformational acquisitions of Urano Energy and Pegasus Resources, which aim to enhance the company’s position in the North American uranium market. The acquisitions are expected to provide access to 15 past-producing uranium mines across 25 properties in the U.S. and bolster exploration efforts in Canada’s Athabasca Basin. Additionally, the company has advanced its U.S. presence by uplisting its shares to the OTCQB under the symbol 'MAUUF', broadening its accessibility to U.S. investors.

Technical Picture

The technical indicators for Manhattan Uranium reveal a challenging landscape. The stock is currently trading below its 50-day moving average of C$0.27, which represents a 13.7% decline, and below its 200-day moving average of C$0.36, indicating a 34.6% drop. The stock has a 52-week range of C$0.19 to C$0.60, positioning it at 11% of its range. With a beta of 1.59, the stock exhibits higher volatility compared to the broader market.

Insider Activity

No recent insider activity has been reported for Manhattan Uranium Discovery Corp., which may indicate a period of stability or a lack of confidence among insiders regarding the company's near-term prospects.

Price Action Summary

Manhattan Uranium Discovery Corp. closed at C$0.23, reflecting a 6.67% increase on Tuesday. Despite this recent uptick, the stock remains down 2.04% for the week and faces significant challenges with a year-to-date decline of 48.94%.

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: September 16, 2026
Last Updated: September 16, 2026
PARTNER SPOTLIGHT

Blue Cross Life® Term Life Insurance

Affordable term life coverage in Canada — get a free quote in seconds, no credit card required.

  • Coverage from $100,000 to $5 million, terms of 10–30 years
  • 10% off first-year premiums when couples apply together
  • Fully digital application — many qualify without a medical exam

Sponsored links

Advertisement